{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T23:22:11Z","timestamp":1771456931073,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T00:00:00Z","timestamp":1374710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s15010-013-0507-y","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T16:29:31Z","timestamp":1374683371000},"page":"199-202","source":"Crossref","is-referenced-by-count":25,"title":["Colistin bladder instillation, an alternative way of treating multi-resistant Acinetobacter urinary tract infection: a case series and review of literature"],"prefix":"10.1007","volume":"42","author":[{"given":"R.","family":"Giua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pedone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Antonelli Incalzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,25]]},"reference":[{"key":"507_CR1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s15010-011-0215-4","volume":"40","author":"G Bayramoglu","year":"2012","unstructured":"Bayramoglu G, Kaya S, Besli Y, Cak\u0131r E, Can G, Ak\u0131neden O, et al. Molecular epidemiology and the clinical significance of Acinetobacter baumannii complex isolated from cerebrospinal fluid in neurosurgical intensive care unit patients. Infection. 2012;40:163\u201372.","journal-title":"Infection"},{"key":"507_CR2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s15010-011-0192-7","volume":"40","author":"YS Cho","year":"2012","unstructured":"Cho YS, Yim H, Yang HT, Hur J, Chun W, Kim JH, et al. Use of parenteral colistin for the treatment of multiresistant Gram-negative organisms in major burn patients in South Korea. Infection. 2012;40:27\u201333.","journal-title":"Infection"},{"key":"507_CR3","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/thorax.58.9.794","volume":"58","author":"TL Pitt","year":"2003","unstructured":"Pitt TL, Sparrow M, Warner M, Stefanidou M. Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents. Thorax. 2003;58:794\u20136.","journal-title":"Thorax"},{"key":"507_CR4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/00063198-200111000-00013","volume":"7","author":"P Beringer","year":"2001","unstructured":"Beringer P. The clinical use of colistin in patients with cystic fibrosis. Curr Opin Pulm Med. 2001;7:434\u201340.","journal-title":"Curr Opin Pulm Med"},{"key":"507_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijantimicag.2004.10.001","volume":"25","author":"J Li","year":"2005","unstructured":"Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents. 2005;25:11\u201325.","journal-title":"Int J Antimicrob Agents"},{"key":"507_CR6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000400132","volume":"31","author":"T Bergan","year":"1982","unstructured":"Bergan T, Fuglesang J. Polymyxin antibiotics: chemical and pharmacokinetic properties. Antibiot Chemother. 1982;31:119\u201344.","journal-title":"Antibiot Chemother"},{"key":"507_CR7","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/infdis\/124.6.610","volume":"124","author":"SD Davis","year":"1971","unstructured":"Davis SD, Iannetta A, Wedgwood RJ. Activity of colistin against Pseudomonas aeruginosa: inhibition by calcium. J Infect Dis. 1971;124:610\u20132.","journal-title":"J Infect Dis"},{"key":"507_CR8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/MMBR.20.1.14-27.1956","volume":"20","author":"BA Newton","year":"1956","unstructured":"Newton BA. The properties and mode of action of the polymyxins. Bacteriol Rev. 1956;20:14\u201327.","journal-title":"Bacteriol Rev"},{"key":"507_CR9","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1021\/bi00587a024","volume":"18","author":"M Schindler","year":"1979","unstructured":"Schindler M, Osborn MJ. Interaction of divalent cations and polymyxin B with lipopolysaccharide. Biochemistry. 1979;18:4425\u201330.","journal-title":"Biochemistry"},{"key":"507_CR10","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","volume":"40","author":"ME Falagas","year":"2005","unstructured":"Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005;40:1333\u201341.","journal-title":"Clin Infect Dis"},{"key":"507_CR11","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/cc3020","volume":"9","author":"A Michalopoulos","year":"2005","unstructured":"Michalopoulos A, Kasiakou SK, Mastora Z, Rellos K, Kapaskelis AM, Falagas ME. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care. 2005;9:R53\u20139.","journal-title":"Crit Care"},{"key":"507_CR12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jinf.2004.05.008","volume":"50","author":"SK Kasiakou","year":"2005","unstructured":"Kasiakou SK, Rafailidis PI, Liaropoulos K, Falagas ME. Cure of post-traumatic recurrent multiresistant Gram-negative rod meningitis with intraventricular colistin. J Infect. 2005;50:348\u201352.","journal-title":"J Infect"},{"key":"507_CR13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1136\/adc.84.5.432","volume":"84","author":"S Cunningham","year":"2001","unstructured":"Cunningham S, Prasad A, Collyer L, Carr S, Lynn IB, Wallis C. Bronchoconstriction following nebulised colistin in cystic fibrosis. Arch Dis Child. 2001;84:432\u20133.","journal-title":"Arch Dis Child"},{"key":"507_CR14","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/thx.52.7.656","volume":"52","author":"ME Dodd","year":"1997","unstructured":"Dodd ME, Abbott J, Maddison J, Moorcroft AJ, Webb AK. Effect of tonicity of nebulised colistin on chest tightness and pulmonary function in adults with cystic fibrosis. Thorax. 1997;52:656\u20138.","journal-title":"Thorax"},{"key":"507_CR15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ijantimicag.2010.05.005","volume":"36","author":"C Nieuwkoop Van","year":"2010","unstructured":"Van Nieuwkoop C, den Exter PL, Elzevier HW, den Hartigh J, van Dissel JT. Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation. Int J Antimicrob Agents. 2010;36:485\u201390.","journal-title":"Int J Antimicrob Agents"},{"key":"507_CR16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1464-410X.1988.tb04293.x","volume":"62","author":"JW Pearman","year":"1988","unstructured":"Pearman JW, Bailey M, Harper WE. Comparison of the efficacy of \u201cTrisdine\u201d and kanamycin-colistin bladder instillations in reducing bacteriuria during intermittent catheterisation of patients with acute spinal cord trauma. Br J Urol. 1988;62:140\u20134.","journal-title":"Br J Urol"},{"key":"507_CR17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/10790268.2006.11753877","volume":"29","author":"KB Waites","year":"2006","unstructured":"Waites KB, Canupp KC, Roper JF, Camp SM, Chen Y. Evaluation of 3 methods of bladder irrigation to treat bacteriuria in persons with neurogenic bladder. J Spinal Cord Med. 2006;29:217\u201326.","journal-title":"J Spinal Cord Med"},{"key":"507_CR18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/10790268.1999.11719578","volume":"22","author":"TA Linsenmeyer","year":"1999","unstructured":"Linsenmeyer TA, Jain A, Thompson BW. Effectiveness of neomycin\/polymyxin bladder irrigation to treat resistant urinary pathogens in those with spinal cord injury. J Spinal Cord Med. 1999;22:252\u20137.","journal-title":"J Spinal Cord Med"},{"key":"507_CR19","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1128\/AAC.01464-06","volume":"51","author":"F Perez","year":"2007","unstructured":"Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51:3471\u201384.","journal-title":"Antimicrob Agents Chemother"},{"key":"507_CR20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1186\/1752-1947-6-426","volume":"6","author":"P Volkow-Fernandez","year":"2012","unstructured":"Volkow-Fernandez P, Rodriguez CF, Cornejo-Juarez P. Intravesical colistin irrigation to treat multidrug-resistant Acinetobacter baumannii urinary tract infection: a case report. J Med Case Rep. 2012;6:426.","journal-title":"J Med Case Rep"},{"key":"507_CR21","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1128\/AAC.45.3.781-785.2001","volume":"45","author":"J Li","year":"2001","unstructured":"Li J, Turnidge J, Milne R, Nation RL, Coulthard K. In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother. 2001;45:781\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"507_CR22","first-page":"223","volume-title":"Infections of the urinary tract. Campbell-Walsh Urology","author":"A Schaeffer","year":"2007","unstructured":"Schaeffer A, Schaeffer E. Infections of the urinary tract. Campbell-Walsh Urology. 9th ed. Philadelphia: Saunders Elsevier; 2007. p. 223\u2013302.","edition":"9"},{"key":"507_CR23","first-page":"S3","volume":"6","author":"MB Siroky","year":"2004","unstructured":"Siroky MB. The aging bladder. Rev Urol. 2004;6:S3\u20137.","journal-title":"Rev Urol"},{"key":"507_CR24","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1128\/IAI.64.12.4922-4927.1996","volume":"64","author":"M Gough","year":"1996","unstructured":"Gough M, Hancock RE, Kelly NM. Antiendotoxin activity of cationic peptide antimicrobial agents. Infect Immun. 1996;64:4922\u20137.","journal-title":"Infect Immun"},{"key":"507_CR25","first-page":"933","volume":"71","author":"K Ramakrishnan","year":"2005","unstructured":"Ramakrishnan K, Scheid DC. Diagnosis and management of acute pyelonephritis in adults. Am Fam Physician. 2005;71:933\u201342.","journal-title":"Am Fam Physician"},{"key":"507_CR26","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1086\/314727","volume":"179","author":"JL Burns","year":"1999","unstructured":"Burns JL, Van Dalfsen JM, Shawar RM, Otto KL, Garber RL, Quan JM, et al. Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis. J Infect Dis. 1999;179:1190\u20136.","journal-title":"J Infect Dis"},{"key":"507_CR27","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1053\/rmed.2000.0834","volume":"94","author":"JM Littlewood","year":"2000","unstructured":"Littlewood JM, Koch C, Lambert PA, H\u00f8iby N, Elborn JS, Conway SP, et al. A ten year review of colomycin. Respir Med. 2000;94:632\u201340.","journal-title":"Respir Med"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-013-0507-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-013-0507-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-013-0507-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T15:16:34Z","timestamp":1596208594000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-013-0507-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,25]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["507"],"URL":"https:\/\/doi.org\/10.1007\/s15010-013-0507-y","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,25]]}}}